A SpaceX Dragon cargo capsule splashed down off the California coast near Oceanside on June 17, 2026, returning to Earth with 3D-printed cartilage, bioprinted organ tissue, cancer research samples, and other biological materials from the International Space Station.
Dragon undocked from the ISS on June 16 after nearly four weeks in orbit. The capsule carried 6,500 pounds of cargo, including samples developed in the microgravity environment of space — conditions impossible to replicate on Earth.
The bioprinted tissue samples represent ongoing research into using space as a unique manufacturing platform. Without gravity, cells and biological materials can organize differently than they would in terrestrial laboratories. Scientists are exploring whether this difference can be harnessed to create tissues with properties useful for medical applications.
The cargo also included heart tissue infected with bacteria for disease research, blood-forming stem cells, and wood-based bone scaffolds designed to address osteoporosis treatment. The materials were maintained in temperature-controlled powered lockers throughout the descent and recovery, preserving their integrity for analysis on the ground.
The Dragon used the upgraded Cargo Dragon 2 design, which features 12 powered lockers capable of maintaining precise environmental conditions for sensitive biological samples. The engineering allows research materials to survive the violent conditions of reentry while remaining viable for study.
This mission represents one of dozens of SpaceX supply runs to the space station. Each carries research materials and equipment supporting ongoing experiments. The bioprinting and tissue engineering samples are among the most scientifically valuable cargo that regularly returns from orbit.
Researchers will analyze the returned samples to understand how microgravity affected tissue development and whether the unique properties justify the cost of manufacturing in space. The work could inform future applications of microgravity manufacturing for medical treatments and regenerative medicine.
